Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/30854
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTENGAN, Fatima Mitiko
dc.contributor.authorFIGUEIREDO, Gerusa M.
dc.contributor.authorNUNES, Arielle K. S.
dc.contributor.authorMANCHIERO, Carol
dc.contributor.authorDANTAS, Bianca P.
dc.contributor.authorMAGRI, Mariana C.
dc.contributor.authorPRATA, Thamiris V. G.
dc.contributor.authorNASCIMENTO, Marisa
dc.contributor.authorMAZZA, Celso C.
dc.contributor.authorABDALA, Edson
dc.contributor.authorBARONE, Antonio A.
dc.contributor.authorBERNARDO, Wanderley M.
dc.date.accessioned2019-02-21T17:24:27Z-
dc.date.available2019-02-21T17:24:27Z-
dc.date.issued2019
dc.identifier.citationINFECTIOUS DISEASES OF POVERTY, v.8, article ID 3, 10p, 2019
dc.identifier.issn2095-5162
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/30854-
dc.description.abstractBackgroundHepatitis E virus (HEV) is a member of the Hepeviridae family; it has four main genotypes and one serotype. While genotypes 1 and 2 cause epidemic hepatitis and are transmitted via water and the fecal-oral route, genotypes 3 and 4 are zoonotic. In the various seroprevalence studies of hepatitis E in Brazil, the numbers reported vary widely and are difficult to interpret. The aim of this study was to analyze existing seroprevalence studies of hepatitis E in adults in Brazil.Main textWe searched the PubMed, Latin American and Caribbean Health Sciences and Embase databases for studies published from inception to May 12, 2018 concerning infection by HEV in Brazil without time period or language restrictions. We included studies that presented data concerning hepatitis E seroprevalence in adults in Brazil, had a sample size 50 patients and whose method used for the detection of anti-HEV was standardized and commercialized. We also evaluated the quality of the articles using a list of criteria that totalized 9 items. Of the 20 studies ultimately analyzed, 10 (50%) were from the southeast region of Brazil, 3 (15%) were from the central-west region, 3 (15%) were from the northern region, 2 (10%) were from the northeast region and 2 (10%) were from the southern region. Regarding the quality evaluation of the studies, the mean score was 5.6 (range: 4-8). The estimated overall seroprevalence of HEV infection in the adult population was 6.0% (95% CI: 5.0-7.0); in subgroup analyses, we observed that the prevalence of anti-HEV antibodies in blood donors was 7.0% (95% CI: 5.0-8.0), whereas in the general population, it was 3.0% (95% CI: 2.0-4.0).ConclusionsThe results of this systematic review indicate that there should be national investment in the prevention of hepatitis E virus infection in Brazil, including the implementation of improvements in basic sanitation and guidance regarding the appropriate handling of animal waste and the optimal cooking of vegetables, meat and their derivatives.eng
dc.language.isoeng
dc.publisherBMCeng
dc.relation.ispartofInfectious Diseases of Poverty
dc.rightsopenAccesseng
dc.subjectHepatitis Eeng
dc.subjectHepatitis E viruseng
dc.subjectBrazileng
dc.subjectPrevalenceeng
dc.subjectSystematic revieweng
dc.subject.othere virus-infectioneng
dc.subject.otherlocal grocery storeseng
dc.subject.otherpig livers soldeng
dc.subject.otherblood-donorseng
dc.subject.othertransplant recipientseng
dc.subject.otherhigh prevalenceeng
dc.subject.otherrisk-factorseng
dc.subject.other1st reporteng
dc.subject.othergenotype 4eng
dc.subject.otherantibodieseng
dc.titleSeroprevalence of hepatitis E in adults in Brazil: a systematic review and meta-analysiseng
dc.typearticleeng
dc.rights.holderCopyright BMCeng
dc.identifier.doi10.1186/s40249-018-0514-4
dc.identifier.pmid30646964
dc.subject.wosInfectious Diseaseseng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalNASCIMENTO, Marisa:Univ Sao Paulo, Sch Med, Clin Hosp, Nursing Div, Sao Paulo, SP, Brazil
hcfmusp.description.articlenumber3
hcfmusp.description.volume8
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000455822000001
hcfmusp.origem.id2-s2.0-85060032636
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceBarnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12eng
hcfmusp.relation.referenceBeale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.xeng
hcfmusp.relation.referenceBEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446eng
hcfmusp.relation.referenceBortoliero André Luiz, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P87, DOI 10.1590/S0036-46652006000200006eng
hcfmusp.relation.referenceBoutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07eng
hcfmusp.relation.referenceBrassard J, 2012, APPL ENVIRON MICROB, V78, P3763, DOI 10.1128/AEM.00251-12eng
hcfmusp.relation.referenceBricks G, 2018, BRAZ J INFECT DIS, V22, P85, DOI 10.1016/j.bjid.2018.02.001eng
hcfmusp.relation.referenceColson P, 2012, EMERG INFECT DIS, V18, P1361, DOI 10.3201/eid1808.111827eng
hcfmusp.relation.referenceCrossan C, 2012, EMERG INFECT DIS, V18, P2085, DOI 10.3201/eid1812.120924eng
hcfmusp.relation.referenceCruells M R, 1997, Gastroenterol Hepatol, V20, P295eng
hcfmusp.relation.referencedos Santos DCM, 2002, MEM I OSWALDO CRUZ, V97, P637, DOI 10.1590/S0074-02762002000500007eng
hcfmusp.relation.referenceEgger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629eng
hcfmusp.relation.referenceFeagins AR, 2008, INT J FOOD MICROBIOL, V123, P32, DOI 10.1016/j.ijfoodmicro.2007.11.068eng
hcfmusp.relation.referenceFeagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0eng
hcfmusp.relation.referenceFerreira AC, 2018, ARCH VIROL, V163, P43, DOI 10.1007/s00705-017-3562-3eng
hcfmusp.relation.referenceFocaccia R, 1998, BRAZ J INFECT DIS, V2, P269eng
hcfmusp.relation.referenceGao SY, 2015, INT J ENV RES PUB HE, V12, P2026, DOI 10.3390/ijerph120202026eng
hcfmusp.relation.referenceGoncales NSL, 2000, CLIN DIAGN LAB IMMUN, V7, P813, DOI 10.1128/CDLI.7.5.813-816.2000eng
hcfmusp.relation.referenceHartl J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080211eng
hcfmusp.relation.referenceHiggins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427eng
hcfmusp.relation.referenceIbarra H, 1997, REV MED CHILE, V125, P275eng
hcfmusp.relation.referenceJeblaoui A, 2013, CLIN INFECT DIS, V57, pE122, DOI 10.1093/cid/cit291eng
hcfmusp.relation.referenceKaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150eng
hcfmusp.relation.referenceKiesslich D, 2002, T ROY SOC TROP MED H, V96, P215, DOI 10.1016/S0035-9203(02)90311-1eng
hcfmusp.relation.referenceKmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111eng
hcfmusp.relation.referenceKokkinos P, 2012, FOOD ENVIRON VIROL, V4, P179, DOI 10.1007/s12560-012-9087-8eng
hcfmusp.relation.referenceLewis HC, 2010, EPIDEMIOL INFECT, V138, P145, DOI 10.1017/S0950268809990847eng
hcfmusp.relation.referencedos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021eng
hcfmusp.relation.referenceMansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371eng
hcfmusp.relation.referenceWassaf MGM, 2014, J CLIN VIROL, V61, P334, DOI 10.1016/j.jcv.2014.08.016eng
hcfmusp.relation.referenceMartins RMB, 2014, J CLIN VIROL, V59, P188, DOI 10.1016/j.jcv.2014.01.002eng
hcfmusp.relation.referenceMeng XJ, 2013, SEMIN LIVER DIS, V33, P41, DOI 10.1055/s-0033-1338113eng
hcfmusp.relation.referenceMeng XJ, 1998, J VIROL, V72, P9714eng
hcfmusp.relation.referenceMoher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.b2535, 10.1002/14651858.CD008242.pub3, 10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1016/j.jclinepi.2010.02.006, 10.1136/bmj.c869]eng
hcfmusp.relation.referenceMunn Z, 2015, INT J EVID-BASED HEA, V13, P147, DOI 10.1097/XEB.0000000000000054eng
hcfmusp.relation.referencede Oliveira JMNS, 2018, INT J INFECT DIS, V69, P41, DOI 10.1016/j.ijid.2018.01.032eng
hcfmusp.relation.referencePANG L, 1995, AM J TROP MED HYG, V52, P347, DOI 10.4269/ajtmh.1995.52.347eng
hcfmusp.relation.referenceParana R, 1997, AM J TROP MED HYG, V57, P60, DOI 10.4269/ajtmh.1997.57.60eng
hcfmusp.relation.referencePassos AM, 2013, J MED VIROL, V85, P615, DOI 10.1002/jmv.23494eng
hcfmusp.relation.referencePassos-Castilho AM, 2017, BRAZ J INFECT DIS, V21, P535, DOI 10.1016/j.bjid.2017.05.004eng
hcfmusp.relation.referencePassos-Castilho AM, 2016, BRAZ J INFECT DIS, V20, P262, DOI 10.1016/j.bjid.2016.03.001eng
hcfmusp.relation.referencePassos-Castilho AM, 2016, J MED VIROL, V88, P361, DOI 10.1002/jmv.24336eng
hcfmusp.relation.referenceSong YJ, 2010, J MED VIROL, V82, P583, DOI 10.1002/jmv.21730eng
hcfmusp.relation.referenceTei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1eng
hcfmusp.relation.referenceTeshale EH, 2015, J INFECT DIS, V211, P366, DOI 10.1093/infdis/jiu466eng
hcfmusp.relation.referenceTrinta KS, 2001, MEM I OSWALDO CRUZ, V96, P25, DOI 10.1590/S0074-02762001000100004eng
hcfmusp.relation.referenceVitral CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-458eng
hcfmusp.relation.referenceYu YH, 2009, INFECT GENET EVOL, V9, P554, DOI 10.1016/j.meegid.2009.02.008eng
dc.description.indexMEDLINEeng
dc.identifier.eissn2049-9957
hcfmusp.citation.scopus24-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MIP
Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - IMT
Instituto de Medicina Tropical - IMT

Artigos e Materiais de Revistas Científicas - LIM/47
LIM/47 - Laboratório de Hepatologia por Vírus

Artigos e Materiais de Revistas Científicas - LIM/52
LIM/52 - Laboratório de Virologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Artigos e Materiais de Revistas Científicas - ODS/06
ODS/06 - Água potável e saneamento


Files in This Item:
File Description SizeFormat 
art_TENGAN_Seroprevalence_of_hepatitis_E_in_adults_in_Brazil_2019.PDFpublishedVersion (English)1.39 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.